^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
TP53-EphA-2-CAR-DC
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Chinese PLA General Hospital
Drug class:
Dendritic cell activator, EphA2 inhibitor
Related drugs:
Phase 1
Chinese PLA General Hospital
Recruiting
Last update posted :
08/28/2023
Initiation :
07/04/2023
Primary completion :
12/30/2025
Completion :
12/30/2026
TP53 • IL6 • IL2 • IL10
|
PD-L1 expression • TP53 mutation • MSI-H/dMMR • TP53 R175H • TP53 R248Q • TP53 R273H
|
Yervoy (ipilimumab) • albumin-bound paclitaxel • cyclophosphamide • TP53-EphA-2-CAR-DC
Share
